Apple (AAPL) tames supply chain hurdles; looks headed for a record year 4 years ago Apple, Inc. (NASDAQ: AAPL) has proved many times that it is one of the most valuable brands, which is popular… Infographic: A snapshot of JetBlue’s (JBLU) Q4 2021 earnings 4 years ago JetBlue Airways Corporation (NASDAQ: JBLU) has reported a narrower net loss for the fourth quarter of 2021 when the aviation… Infographic: A snapshot of McDonald’s Q4 2021 earnings 4 years ago McDonald’s Corporation (NYSE: MCD) this week reported a sharp increase in fourth-quarter earnings, supported by a 13% increase in revenues.… Visa (V) bets on multi-pronged growth strategy to deliver strong results in future 4 years ago Credit card giant Visa Inc. (NYSE: V) this week reported higher earnings and revenues for the first quarter of 2022… Caterpillar stock remains weak despite Q4 earnings beat 4 years ago Caterpillar (NYSE: CAT) reported fourth-quarter 2021 financial results before the regular market hours on Friday. The industrial giant reported Q4… Key highlights from Chevron (CVX) Q4 2021 earnings results 4 years ago Chevron Corporation (NYSE: CVX) reported fourth-quarter 2021 earnings results today. Total revenues amounted to $48.1 billion compared to $25.2 billion… INTC Stock: Intel set to gain from stable sales, capacity expansion this year 4 years ago Intel Corporation (NASDAQ: INTC) has been on an aggressive expansion drive to strengthen its foothold in the semiconductor industry. The… Southwest Airlines (LUV) beats market estimates in Q4 4 years ago Southwest Airlines (NYSE: LUV) reported fourth-quarter 2021 financial results before the regular market hours on Thursday. The aviation company reported… Microsoft (MSFT) becomes a compelling buy after strong earnings, Activision deal 4 years ago Microsoft Corp. (NASDAQ: MSFT) is one of the most innovative technology companies, constantly transforming the business to align with the… INTERVIEW: Evelo’s SINTAX medicines could address a broad range of inflammatory disorders 4 years ago Evelo Biosciences (Nasdaq:EVLO) is a clinical-stage biotechnology company that is focused on a newly uncovered area of central human biology… Next» « Previous